Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.
Sign Up to like & getrecommendations! Published in 2021 at "Blood"
DOI: 10.1182/blood.2021010867
Abstract: Relapsed myeloid disease after allogeneic stem cell transplantation (HSCT) remains largely incurable. We previously demonstrated the potent activity of immune checkpoint blockade (ICB) in this clinical setting with ipilimumab or nivolumab. To define the molecular… read more here.
Keywords: molecular cellular; blockade; cellular features; cell ... See more keywords